| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
27,030,000 |
| Market
Cap: |
128.12(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.68 - $13.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VistaGen Therapeutics is a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company engaging in the treatment for individuals living with anxiety, depression and other CNS disorders. Co.'s product candidates include: PH94B, which is a synthetic investigational pherine nasal spray with a mechanism of action (MOA) that regulates the olfactory-amygdala neural circuits of fear and anxiety and attenuates the tone of the sympathetic autonomic nervous system; and PH10, which is a synthetic investigational pherine nasal spray with a rapid-onset potential MOA that is fundamentally differentiated from the MOA of existing approved treatments for depression disorders.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
775,756 |
1,875,756 |
| Total Buy Value |
$0 |
$0 |
$17,961,079 |
$18,150,929 |
| Total People Bought |
0 |
0 |
1 |
4 |
| Total Buy Transactions |
0 |
0 |
1 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
60,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$53,400 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-12-29 |
4 |
A |
$1.72 |
$287 |
D/D |
167 |
5,633 |
|
- |
|
| Adler Reid G. |
CHF CORP DEVEL OFF, GEN COUNS |
• – – |
2023-12-29 |
4 |
A |
$1.72 |
$287 |
D/D |
167 |
11,655 |
|
- |
|
| Commodore Capital Lp |
10% Owner |
– – • |
2023-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
799,244 |
|
-64% |
|
| Commodore Capital Lp |
10% Owner |
– – • |
2023-08-07 |
4 |
B |
$23.15 |
$17,961,079 |
I/I |
775,756 |
1,575,000 |
1.5 |
-64% |
|
| Dotson Jerrold Duane |
VP, CFO |
• – – |
2023-06-30 |
4 |
A |
$1.59 |
$265 |
D/D |
167 |
3,671 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-06-30 |
4 |
A |
$1.59 |
$265 |
D/D |
167 |
5,466 |
|
- |
|
| Adler Reid G. |
CHIEF LEGAL OFFICER |
• – – |
2023-06-30 |
4 |
A |
$1.59 |
$265 |
D/D |
167 |
11,488 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-30 |
4 |
A |
$0.09 |
$438 |
D/D |
5,000 |
158,998 |
|
- |
|
| Dotson Jerrold Duane |
VP, CFO AND SECRETARY |
• – – |
2022-12-30 |
4 |
A |
$0.09 |
$438 |
D/D |
5,000 |
105,111 |
|
- |
|
| Gin Jerry B |
|
– • – |
2022-08-18 |
4 |
B |
$0.18 |
$17,870 |
I/I |
100,000 |
100,000 |
0.01 |
-58% |
|
| Gin Jerry B |
|
– • – |
2022-08-18 |
4 |
B |
$0.18 |
$17,870 |
D/D |
100,000 |
100,000 |
0.01 |
-58% |
|
| Adler Reid G. |
CHIEF LEGAL OFFICER |
• – – |
2022-08-17 |
4 |
B |
$0.17 |
$50,910 |
D/D |
300,000 |
334,629 |
0.01 |
-58% |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-08-17 |
4 |
B |
$0.17 |
$103,200 |
I/I |
600,000 |
626,234 |
0.01 |
-58% |
|
| Dotson Jerrold Duane |
VP, CFO AND SECRETARY |
• – – |
2022-07-30 |
4 |
A |
$0.75 |
$3,740 |
D/D |
5,000 |
100,111 |
|
- |
|
| Shah Nimish P |
10% Owner |
– – • |
2022-07-12 |
4 |
S |
$0.89 |
$53,400 |
I/I |
(60,000) |
20,637,286 |
|
83% |
|
| Smith Mark Alan |
CHIEF MEDICAL OFFICER |
• – – |
2022-06-30 |
4 |
A |
$0.75 |
$3,740 |
D/D |
5,000 |
19,915 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-06-30 |
4 |
A |
$0.75 |
$3,740 |
D/D |
5,000 |
153,998 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-05-12 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
148,998 |
|
- |
|
| Adler Reid G. |
CHIEF LEGAL OFFICER |
• – – |
2022-05-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,629 |
|
-84% |
|
| Shah Nimish P |
10% Owner |
– – • |
2022-04-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,697,286 |
|
-88% |
|
| Dotson Jerrold Duane |
VP, CFO AND SECRETARY |
• – – |
2022-01-11 |
4 |
OE |
$1.00 |
$18,750 |
D/D |
18,750 |
94,571 |
|
- |
|
| Snodgrass H. Ralph |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-12-31 |
4 |
A |
$1.66 |
$6,005 |
D/D |
3,623 |
64,958 |
|
- |
|
| Dotson Jerrold Duane |
VP, CFO AND SECRETARY |
• – – |
2021-12-31 |
4 |
A |
$1.66 |
$5,926 |
D/D |
3,575 |
75,821 |
|
- |
|
| Smith Mark Alan |
CHIEF MEDICAL OFFICER |
• – – |
2021-12-31 |
4 |
A |
$1.66 |
$4,401 |
D/D |
2,655 |
14,915 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2021-12-31 |
4 |
A |
$1.66 |
$6,005 |
D/D |
3,623 |
48,998 |
|
- |
|
70 Records found
|
|
Page 1 of 3 |
|
|
0.09 (1.86%) 
